Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

Autor: Simon Turcotte, Sangeetha Prabhakaran, Steven A. Rosenberg, Haider Mahdi, Carol D. Morris, Howard L. Kaufman, Sara I. Pai, Yuman Fong, Michael Lim, John B. Sunwoo, Matthew M. Grabowski, Joseph J. Skitzki, Michael T. Lotze, Stephen Broderick, Pranav Murthy, Cecilia C.S. Yeung, Craig L. Slingluff, Adekunle Odunsi, David R. Byrd, Fumito Ito, Rogerio I. Neves, Lisa H. Butterfield, Brian R. Gastman, Peter E. Fecci, Genevieve M. Boland, Vernon K. Sondak, Adam C. Berger, Piyush K. Agarwal, Jyothi Sethuraman, Robert L. Ferris, Ragheed Saoud, Mokenge P. Malafa, Stephanie L. Goff
Rok vydání: 2020
Předmět:
0301 basic medicine
Cancer Research
medicine.medical_specialty
tumor
Tissue and Organ Procurement
Best practice
medicine.medical_treatment
Clinical Trials and Supportive Activities
Immunology
review
Review
Subspecialty
Medical Oncology
Biospecimen Collection
Tissue procurement
03 medical and health sciences
Rare Diseases
0302 clinical medicine
Cancer immunotherapy
Clinical Research
Immunology and Allergy
Medicine
Humans
Medical physics
RC254-282
Cancer
Pharmacology
screening and diagnosis
Clinical Trials as Topic
business.industry
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
biomarkers
Immunotherapy
4.5 Resources and infrastructure (detection)
Clinical trial
Detection
Orphan Drug
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
Molecular Medicine
Immunization
immunotherapy
business
Cancer surgery
guidelines as topic
Zdroj: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for immunotherapy of cancer, vol 8, iss 2
ISSN: 2051-1426
Popis: Immunotherapy is now a cornerstone for cancer treatment, and much attention has been placed on the identification of prognostic and predictive biomarkers. The success of biomarker development is dependent on accurate and timely collection of biospecimens and high-quality processing, storage and shipping. Tumors are also increasingly used as source material for the generation of therapeutic T cells. There have been few guidelines or consensus statements on how to optimally collect and manage biospecimens and source material being used for immunotherapy and related research. The Society for Immunotherapy of Cancer Surgery Committee has brought together surgical experts from multiple subspecialty disciplines to identify best practices and to provide consensus on how best to access and manage specific tissues for immuno-oncology treatments and clinical investigation. In addition, the committee recommends early integration of surgeons and other interventional physicians with expertise in biospecimen collection, especially in clinical trials, to optimize the quality of tissue and the validity of correlative clinical studies in cancer immunotherapy.
Databáze: OpenAIRE